9:59 AM
 | 
May 16, 2018
 |  BC Extra  |  Financial News

EIP gets $20.5M to develop AD candidate

CNS company EIP Pharma LLC (Cambridge, Mass.) raised $20.5 million in a series B round led by new investor Access Industries. Other individual investors participated....

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >